作者: Filip Mussen

支持
Dr Sam Salek, Reader in Pharmacoepidemiology, Director – WSP Centre for Socioeconomic Research; Director – Postgraduate Course in Pharmaceutical Medicine, Cardiff University, UK. Mr Filip Mussen, Johnson & Johnson Pharmaceuticals Research and Development, Belgium. Prof Stuart Walker, President and Founder, International Institute for Regulatory Science, UK.




1 电子书 Filip Mussen

Filip Mussen & Sam Salek: Benefit-Risk Appraisal of Medicines
Benefit-risk assessment is at the centre of the approval process for every new medicine. The ability to assess the risks of a new medicine accurately and to balance these against the benefits the med …
PDF
英语
DRM
€97.99